Brooklyn biotech files 40-claim patent application covering a new active-ingredient combination for over-the-counter headache ...
PITTSBURGH, Nov. 27, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (KRYS) (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development and ...
After an FDA rejection in May, Stealth BioTherapeutics has resubmitted a new drug application for its investigational treatment designed to treat an ultra-rare genetic disease. This is the biotech’s ...
PITTSBURGH, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Krystal Biotech, Inc. (the “Company”) (NASDAQ: KRYS), a commercial-stage biotechnology company focused on the discovery, development, and ...
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, March 9, 2026 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of ...
DUBLIN, Ireland, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Trinity Biotech Plc (TRIB). (the “Company”) today announced that its New York based reference laboratory, Immco Diagnostics, has applied for a ...
Figuring out how long it's taken the Multidisciplinary Association for Psychedelic Studies' (MAPS) application to reach the FDA’s desk all depends on when you start counting. The organization was ...
This signing marks the establishment of a long-term strategic partnership between Cathay Biotech and Fuyang Investment in the application of bio-based composite materials industry. In Fuyang, Anhui ...
Array BioPharma Inc. said it's withdrawing its application of its treatment of a rare type of skin cancer to the U.S. Food and Drug Administration. The Boulder biotech said it's withdrawn its new drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results